Your browser doesn't support javascript.
loading
Practical considerations when providing palliative care to patients with neuroendocrine tumors in the context of routine disease management or hospice care.
Del Rivero, Jaydira; Mailman, Josh; Rabow, Michael W; Chan, Jennifer A; Creed, Sarah; Kennecke, Hagen F; Pasieka, Janice; Zuar, Jennifer; Singh, Simron; Fishbein, Lauren.
Afiliación
  • Del Rivero J; Developmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, USA.
  • Mailman J; NorCal CarciNET Community, Oakland, California, USA.
  • Rabow MW; Department of Internal Medicine, Division of Palliative Medicine, University of California, San Francisco, San Francisco, California, USA.
  • Chan JA; Harvard Medical School, Program in Carcinoid and Neuroendocrine Tumors, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Creed S; Good Shepherd Community Care, Harvard Kennedy School, Natick, Massachusetts, USA.
  • Kennecke HF; Providence Cancer Institute Franz Clinic, Portland Providence Medical Center, Portland, Oregon, USA.
  • Pasieka J; Department of Surgery, Section of General Surgery, University of Calgary, Cumming School of Medicine, Calgary, Canada.
  • Zuar J; Department of Internal Medicine, Division of Geriatrics and Palliative Medicine, Alpert Medical School, Providence, Rhode Island, USA.
  • Singh S; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Fishbein L; Department of Medicine, Division of Endocrinology, Metabolism and Diabetes, Department of Biomedical Informatics, University of Colorado School of Medicine, Aurora, Colorado, USA.
Endocr Relat Cancer ; 30(7)2023 07 01.
Article en En | MEDLINE | ID: mdl-37017232
ABSTRACT
This serves as a white paper by the North American Neuroendocrine Tumor Society (NANETS) on the practical considerations when providing palliative care to patients with neuroendocrine tumors in the context of routine disease management or hospice care. The authors involved in the development of this manuscript represent a multidisciplinary team of patient advocacy, palliative care, and hospice care practitioners, endocrinologist, and oncologists who performed a literature review and provided expert opinion on a series of questions often asked by our patients and patient caregivers affected by this disease. We hope this document serves as a starting point for oncologists, palliative care teams, hospice medical teams, insurers, drug manufacturers, caregivers, and patients to have a frank, well-informed discussion of what a patient needs to maximize the quality of life during a routine, disease-directed care as well as at the end-of-life.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Cuidados Paliativos al Final de la Vida / Tumores Neuroendocrinos Límite: Humans Idioma: En Revista: Endocr Relat Cancer Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Cuidados Paliativos al Final de la Vida / Tumores Neuroendocrinos Límite: Humans Idioma: En Revista: Endocr Relat Cancer Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos